Liraglutide Evidence level : FDA approved (Saxenda), extensive research SCALE trials : SCALE Obesity (Pi-Sunyer et al., 2015): 3,731 participants 56 weeks Result: 8.4% weight loss vs 2.8% placebo 33% achieved 10% weight loss Mechanism : Earlier-generation GLP-1 agonist, daily injection required
Defective autophagic degradation promotes accumulation of intracellular autoantigens and enhances presentation of self-derived peptides, contributing to loss of self-tolerance
Ceramide accumulation induces mitophagy and impairs -oxidation in PINK1 deficiency
What We Offer Personalized Anti-Aging Treatments Collagen-Boosting Therapy Skin Hydration and Restoration Dont miss a Drip Have questions or need assistance
Animal cognition studies: Rats treated with Dihexa show dramatically improved performance on spatial memory tasks, with some studies suggesting effects comparable to reversing years of age-related cognitive decline
Among the GLP-1 RAs, evidence of CV benefit is strongest for liraglutide, favorable for semaglutide, and less certain for exenatide
